The promise of IL-1β modulation in NSCLC clinical context. [PDF]
Ghiringhelli F, Rébé C.
europepmc +1 more source
Genotype-phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond borders. [PDF]
Bayindir Y +6 more
europepmc +1 more source
Three-year follow-up of canakinumab dose extension in children with colchicine-resistant familial Mediterranean fever: PeRA-RG Experience. [PDF]
Kavrul Kayaalp G +14 more
europepmc +1 more source
Evaluation of the real-world safety of Canakinumab in the treatment of systemic juvenile idiopathic arthritis in children aged 0-16: a comprehensive analysis based on FAERS data. [PDF]
Xiao P +8 more
europepmc +1 more source
Structural and functional evolution of IL-1 targeting: From systemic neutralization to bioengineered nanotherapies. [PDF]
Yang L, Chen G, Lyu Z.
europepmc +1 more source
Pharmacologic management of renal involvement in monogenic autoinflammatory diseases. [PDF]
Fayed A +4 more
europepmc +1 more source
Molecular cancer prevention: Intercepting disease. [PDF]
Grieco C, Pandya T, Swanton C.
europepmc +1 more source
Neonatal-onset multisystem inflammatory disease caused by a <i>de novo NLRP3</i> gene mutation: a case report and literature review. [PDF]
Zhao L, Zeng L, Yuan W.
europepmc +1 more source
Clonal hematopoiesis of indeterminate potential and cardiovascular disease: mechanistic insights, clinical implications, and the dawn of precision cardio-hematology. [PDF]
Wu H, Meng X, Li L, Zhang C.
europepmc +1 more source
Growth Outcomes in Children with Familial Mediterranean Fever: A Question Beyond Chronic or Relapsing Inflammation. [PDF]
Cammisa I, Cipolla C, Rigante D.
europepmc +1 more source

